Prescribing medical cannabis to patients with chronic health conditions may improve health-related quality of life.

Following clinicians’ implementation of the 2010 ACR criteria, fibromyalgia diagnoses nearly doubled, from 0.58% in 2010 to 0.99% in 2011, then stabilized at approximately 0.80% through 2014. After ...

HealthDay News — Fisher-Price has recalled 253,000 baby stroller toys in the U.S. because of a choking risk, according to the U.S. Consumer Product Safety Commission (CPSC). An additional 4,500 toys ...

Researchers determined painful crises remain a consistent risk among pregnant patients with SCD who have abortion procedures or early pregnancy loss.

All-cause mortality increased in 2020 to 2021 nationwide, with a slower increase in Medicaid expansion states.

According to a recent study, low oral health scores are associated with higher pain scores, including migraine headache, among women.

Thirty-five percent of Americans surveyed said they are unable to access affordable, quality health care when needed.

Advice was presented for clinicians regarding the benefits and harms of cannabis or cannabinoids for the management of chronic noncancer pain.

Weeks after ordering staff back to the office, the US Food and Drug Administration is now letting some employees work from home again.

The FDA has accepted for review the sBLA for fremanezumab-vfrm for the prevention of episodic migraine in pediatric patients aged 6 to-17 years weighing at least 45 kg.

[O]ur study indicates that inadequate pain control, leading to prolonged pain duration, puts patients at a higher risk of sensory impairments, particularly in vision, smell, and taste functions.

Galcanezumab for migraine prevention had higher direct costs over 24 months but superior adherence and longer treatment duration compared with standard care.